Table 4.
The difference of prognostic factors between OS (−) group and OS (+) group
| Values | OS (−) | OS (+) | Statistic(χ2) | P-value |
|---|---|---|---|---|
| N | 34 | 18 | ||
| Platelet | 4.294 | 0.039 | ||
| Increase | 9(26.5%) | 10(55.6%) | ||
| Decrease | 25(73.5%) | 8(44.4%) | ||
| D-dimer | 1.353 | 0.337 | ||
| Increase | 8(23.5%) | 7(38.9%) | ||
| Decrease | 26(76.5%) | 11(61.1%) | ||
| Gender | 8.497 | 0.008 | ||
| Male | 12(35.3%) | 14(77.8%) | ||
| Female | 22(64.7%) | 4(22.2%) | ||
| Age | 3.059 | 0.072 | ||
| ≥ 62.5 | 14(41.2%) | 12(66.7%) | ||
| < 62.5 | 20(58.8%) | 6(33.3%) | ||
| Smoking | 6.540 | 0.013 | ||
| Past/current | 27(79.4%) | 8(44.4%) | ||
| Never | 7(20.6%) | 10(55.6%) | ||
| Exon21 | 0.575 | 0.519 | ||
| No | 26(76.5%) | 12(66.7%) | ||
| Yes | 8(23.5%) | 6(33.3%) | ||
| Exon19 | 0.001 | 0.605 | ||
| No | 19(55.9%) | 10(55.6%) | ||
| Yes | 15(44.1%) | 8(44.4%) | ||
| Other diseases | 5.967 | 0.016 | ||
| No | 25(73.5%) | 7(38.9%) | ||
| Yes | 9(26.5%) | 11(61.1%) | ||
| Other treatment | 1.549 | 0.172 | ||
| No | 11(32.4%) | 9(50%) | ||
| Yes | 23(67.6%) | 9(50%) |
OS overall survival, OS (−) survival group, OS (+) death group